Leverage Cognate’s Unparalleled Cell-Based cGMP manufacturing expertise combined with a broad spectrum of targeted services for effective and optimized commercialization.
International experience providing full support through out all stages of commercial development. Cognate provides the most efficient translation from concept to market.
Cell Therapy Services
Access an array of technical and specialized manufacturing and development services backed by an unsurpassed track record and proven expertise with cell-based technologies.
Outstanding real-world experience in navigating the evolving international regulatory pathways coupled with global know-how in translating cGMP manufacturing between countries.
Notable Industry News
- Novartis circles back with new terms for a stem cell biotech buyout–report Read more →
- Addition of lentiviral gene delivery capabilities complements strategic partnering portfolio. Read more →
- Cardium Announces Review in Journal Of Cardiovascular Pharmacology Finds Gene Therapy For Subset Of Heart Disease Patients ‘Highly Warranted’ Read more →